ReviewLeukemia2025
Pre-emptive therapeutic decisions based on measurable residual disease status in acute myeloid leukemia: ready for prime time?
Firas El Chaer et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it